statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Greenwich LifeSciences (GLSI, $20.32) RSI Indicator left the overbought zone on March 26, 2024

This is a signal that GLSI's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

Insiders Buying Greenwich LifeSciences And 2 Other Stocks

Although U.S. stocks closed mostly lower on Friday, there were a few notable insider trades.
read more...

Greenwich LifeSciences (GLSI, $19.66) RSI Indicator left the overbought zone on March 22, 2024

Greenwich LifeSciences (GLSI, $16.57) RSI Indicator left the overbought zone on March 14, 2024

Greenwich LifeSciences extends lock-up of directors and officers

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Greenwich LifeSciences Extends Lock-up of Directors and Officers to June 30, 2025

STAFFORD, Texas, March 13, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial...

Greenwich LifeSciences Partners with GEICAM in Spain & Conducts First Site Initiation Visits in Europe

STAFFORD, Texas, March 12, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial...

Greenwich LifeSciences (GLSI, $17.68) RSI Indicator left the overbought zone on March 11, 2024

Greenwich LifeSciences (GLSI, $15.35) RSI Indicator left the overbought zone on March 08, 2024

Greenwich LifeSciences (GLSI, $16.49) RSI Indicator left the overbought zone on March 07, 2024

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Volume	34,885.00
52-Wk High	$21.44
52-Wk Low	$7.58

GLSI Greenwich LifeSciences Inc

About

Feed

News

Fundamentals